J. Newton

发表

Screening for cognition and behaviour changes in ALS

Elaine Niven, T. Bak, J. Foley, 2014, Amyotrophic lateral sclerosis & frontotemporal degeneration.

An epidemiological profile of dysarthria incidence and assistive technology use in the living population of people with MND in Scotland

S. Chandran, S. Colville, S. Pal, 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland

S. Chandran, M. Connor, S. Colville, 2020, Journal of Neurology.

Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): A cognitive tool for motor disorders

S. Chandran, T. Bak, J. Foley, 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Cell-autonomous immune dysfunction driven by disrupted autophagy in C9orf72-ALS iPSC-derived microglia contributes to neurodegeneration

James D. Cooper, Colin Smith, S. Chandran, 2022, bioRxiv.

Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron disease

S. Chandran, J. Chataway, M. Parmar, 2022, BMJ Open.

Improved survival and 30-day mortality after gastrostomy in Scottish motor neurone disease patients: evidence from a national retrospective cohort study using STROBE criteria

S. Chandran, R. Forbes, M. Hair, 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.

A systematic review of digital technology to evaluate motor function and disease progression in motor neuron disease

S. Chandran, S. Abrahams, S. Pal, 2022, Journal of Neurology.

A systematic review of digital technology to evaluate motor function and disease progression in motor neuron disease

S. Chandran, S. Abrahams, S. Pal, 2022, Journal of Neurology.

Mitochondrial bioenergetic dysfunction and cryptic splicing of stathmin-2 are neuropathological markers of disease duration in sporadic amyotrophic lateral sclerosis

M. Ruepp, A. Mehta, C. Smith, 2022, medRxiv.

Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland

I. Deary, S. Chandran, J. Prendergast, 2022, Journal of Neurology.

The brief Dimensional Apathy Scale: A short clinical assessment of apathy

J. Starr, S. Chandran, S. Abrahams, 2020, The Clinical neuropsychologist.

Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis

D. Lulé, Colin Smith, S. Chandran, 2017, Acta Neuropathologica.

The immediate impact of the COVID-19 pandemic on motor neuron disease services and mortality in Scotland

S. Chandran, M. Connor, S. Pal, 2020, Journal of Neurology.

A systematic review of non-motor symptom evaluation in clinical trials for amyotrophic lateral sclerosis

S. Chandran, S. Abrahams, S. Pal, 2021, Journal of Neurology.

A systematic review of neuropsychiatric and cognitive assessments used in clinical trials for amyotrophic lateral sclerosis

S. Chandran, S. Abrahams, S. Pal, 2020, Journal of Neurology.

Theme 11 Cognitive and psychological assessment and support

S. Chandran, M. C. Carboncini, S. Abrahams, 2018, Amyotrophic lateral sclerosis & frontotemporal degeneration.

ECAS A-B-C: alternate forms of the Edinburgh Cognitive and Behavioural ALS Screen

A. Al-Chalabi, O. Hardiman, T. Bak, 2018, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Measuring reliable change in cognition using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS)

A. Al-Chalabi, O. Hardiman, S. Abrahams, 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.

ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS

A. Al-Chalabi, C. Shaw, O. Hardiman, 2018, Neurology.

Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective

M. Macleod, S. Chandran, J. Chataway, 2021, Brain communications.

Prospective observational cohort study of factors influencing trial participation in people with motor neuron disease (FIT-participation-MND): a protocol

S. Chandran, S. Abrahams, S. Pal, 2021, BMJ Open.

Theme 5 Epidemiology and informatics

A. Al-Chalabi, S. Chandran, L. Ossher, 2018, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Multidimensional apathy and executive dysfunction in amyotrophic lateral sclerosis

S. Chandran, S. Abrahams, Ratko Radakovic, 2017, Cortex.

A weight-reduction program for schizophrenic patients on a token economy unit: Two case studies

J. Newton, D. Upper, 1971 .

Prevalence of multimorbidity and its impact on survival in people with motor neuron disease

S. Chandran, S. Pal, C. Weir, 2021, European journal of neurology.

Motor Neuron Disease is not clustered or associated with socioeconomic deprivation in Scotland.

S. Chandran, M. Connor, S. Pal, 2022, medRxiv.

Clinical audit research and evaluation of motor neuron disease (CARE-MND): a national electronic platform for prospective, longitudinal monitoring of MND in Scotland

S. Chandran, S. Abrahams, S. Colville, 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.

The Prevalence and Management of Saliva Problems in Motor Neuron Disease: A 4-Year Analysis of the Scottish Motor Neuron Disease Register

S. Chandran, S. Pal, A. Mehta, 2021, Neurodegenerative Diseases.

ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS

A. Al-Chalabi, C. Shaw, O. Hardiman, 2018, Neurology.

Reliability and validity of the brief dimensional apathy scale.

S. Chandran, S. Abrahams, Ratko Radakovic, 2020, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): A cognitive tool for motor disorders

S. Colville, J. Newton, Elaine H. Niven, 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.

National audit of cognitive assessment in people with pwMND A national audit of cognitive assessment in people with motor neurone disease (pwMND) in Scotland

S. Chandran, S. Abrahams, S. Colville, 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Factors impacting trial participation in people with motor neuron disease

S. Pal, J. Newton, Rachel S Dakin, 2023, Journal of neurology.

ECAS A-B-C: alternate forms of the Edinburgh Cognitive and Behavioural ALS Screen

A. Al-Chalabi, O. Hardiman, T. Bak, 2018, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Improved survival and 30-day mortality after gastrostomy in Scottish motor neurone disease patients: evidence from a national retrospective cohort study using STROBE criteria

S. Chandran, R. Forbes, M. Hair, 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia

H. Leonard, D. Knopman, C. van Broeckhoven, 2024, American journal of human genetics.

Genotypes and phenotypes of motor neuron disease: an update of the genetic landscape in Scotland

S. Pal, J. Newton, G. Gorrie, 2024, Journal of neurology.